Article Details

Lixte Biotechnology Holdings' $5.7 Million Offering of Common Stock and Warrants

Retrieved on: 2021-01-27 08:26:15

Tags for this article:

Click the tags to see associated articles and topics

Lixte Biotechnology Holdings' $5.7 Million Offering of Common Stock and Warrants. View article details on hiswai:

Excerpt

Lixte Biotechnology Holdings, Inc. (“Lixte” or the “Company”) (Nasdaq: Common stock – LIXT; Warrants – LIXTW), a drug discovery company that uses ...

Article found on: www.globallegalchronicle.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up